DAFTAR PUSTAKA

1. Crago AM dan Dickson MA. Liposarcoma: multimodality management and

future targeted therapies. Surg Oncol Clin N Am. 2016; 25(4): 761–773
2. Anderson WJ dan Jo VY. Pleomorphic liposarcoma: Updates and current
differential diagnosis. Seminars in Diagnostic Pathology. 2019
3. Fitrikalinda. Karakteristik Gambaran Histopatologi Liposarkoma di Laboratorium
Patologi Anatomik FK USU / Unit Patologi Anatomik RSUP H. Adam Malik
Medan Tahun 2016-2018. Tesis. Universitas Sumatera Utara. 2019
4. Azamris, Handayani P, Rifki M. Mixoid Liposarcoma. Jurnal Kesehatan Andalas.
2016; 5(3)
5. Lee ATJ et al. Clinical and Molecular Spectrum of Liposarcoma. J Clin Oncol.
2018 Jan 10; 36(2): 151–159.
6. Liposarcoma. Dalam: Weiss SW, Goldblum JR. Enzinger & Weiss’s soft tissue
tumors. Edisi ke-5. Philadelphia. Mosby-Elsevier Inc; 2008. hlm. 477–510.
7. Fletcher CDM. World Health Organization., and International Agency for
Research on Cancer. WHO Classification of Tumours of Soft Tissue and Bone.
4th ed. Lyon: World Health Organization classification of tumoursIARC Press;
2013:468
8. Ida Hartati dan Sjahjenny Mustokoweni. 2015. Hubungan Ekspresi CD8 dengan
Skor Diferensiasi Liposarkoma. Surabaya : Jurnal Departemen Patologi
Anatomik, Fakultas Kedokteran, Universitas Airlangga. Vol. 24 No. 2.
9. Hornick JL. Biologic Potential, Grading, Staging, and Reporting of Sarcomas.
Dalam: Hornick JL. Practical Soft Tissue Pathology: A Diagnostic Approach 2 nd
Edition. 2018
10. Sjamsuhidajat, R.,1997. Buku Ajar Ilmu Bedah.EGC.Jakarta.
11. Khan AN, Chandramohan M, Macdonald S, Alkubaidan FO. Liposarcoma
Imaging. Diakses melalui http://emedicine.medscape.com/article/391272-
overview
12. Department of Health Western Australia. Diagnostic Imaging Pathways – Soft
Tissue Mass. Diakses melalui
http://www.imagingpathways.health.wa.gov.au/index.php/imaging-
pathways/musculoskeletal-trauma/musculoskeletal/soft-tissue-mass#pathway
13. Abd Rabou and Gaillard.et al Diakses melalui .https://radiopaedia.org/article
14.